NCT03377023 2026-04-02Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung CancerH. Lee Moffitt Cancer Center and Research InstitutePhase 1/2 Active not recruiting66 enrolled 17 charts